Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Kirsa

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Gastroenterology and Hepatology|March 19, 2016
Monoclonal antibodies safety and occupational hazard: Current practice in AustraliaSue Kirsa
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 8, 2009
Reducing workplace cytotoxic surface contamination using a closed-system drug transfer deviceJim Siderov, Sue Kirsa, Robert McLauchlan
Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidenceMarliese Alexander, Sue Kirsa, James D Mellor
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 2, 2012
A controlled before and after study to evaluate a patient and health professional partnership model towards effective medication reconciliationSenthil Lingaratnam, Sanchia Aranda, Tracy Pearce, et al.
Social Psychiatry and Psychiatric Epidemiology|June 6, 2022
Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysisLouise Lord, David McKernon, Luke Grzeskowiak, et al.
Asia-Pacific Journal of Clinical Oncology|December 21, 2013
Challenging historical perspectives of the 24-h chemotherapy day: Flexible chemotherapy dose-timing guidelinesMarliese Alexander, Frank Coenders, Danielle Murray, et al.
Asia-Pacific Journal of Clinical Oncology|September 25, 2012
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospitalMarliese Alexander, Khai C Teoh, Senthil Lingaratnam, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2014
A review of the evidence for occupational exposure risks to novel anticancer agents - A focus on monoclonal antibodiesJulie King, Marliese Alexander, Jenny Byrne, et al.
Journal of Psychosomatic Research|August 23, 2024
Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022Louise Lord, Peter Wark, Mark Hew, et al.
Journal of the American Pharmacists Association : Japha|August 31, 2025
Application of health data analytics in pharmacy - An innovative approach to developing a heart failure dashboardViviane Khalil, Hannah Doody, Adam J Nelson, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology and Hepatology|March 19, 2016
Monoclonal antibodies safety and occupational hazard: Current practice in AustraliaSue Kirsa
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 8, 2009
Reducing workplace cytotoxic surface contamination using a closed-system drug transfer deviceJim Siderov, Sue Kirsa, Robert McLauchlan
Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidenceMarliese Alexander, Sue Kirsa, James D Mellor
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 2, 2012
A controlled before and after study to evaluate a patient and health professional partnership model towards effective medication reconciliationSenthil Lingaratnam, Sanchia Aranda, Tracy Pearce, et al.
Social Psychiatry and Psychiatric Epidemiology|June 6, 2022
Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysisLouise Lord, David McKernon, Luke Grzeskowiak, et al.
Asia-Pacific Journal of Clinical Oncology|December 21, 2013
Challenging historical perspectives of the 24-h chemotherapy day: Flexible chemotherapy dose-timing guidelinesMarliese Alexander, Frank Coenders, Danielle Murray, et al.
Asia-Pacific Journal of Clinical Oncology|September 25, 2012
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospitalMarliese Alexander, Khai C Teoh, Senthil Lingaratnam, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 18, 2014
A review of the evidence for occupational exposure risks to novel anticancer agents - A focus on monoclonal antibodiesJulie King, Marliese Alexander, Jenny Byrne, et al.
Journal of Psychosomatic Research|August 23, 2024
Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022Louise Lord, Peter Wark, Mark Hew, et al.
Journal of the American Pharmacists Association : Japha|August 31, 2025
Application of health data analytics in pharmacy - An innovative approach to developing a heart failure dashboardViviane Khalil, Hannah Doody, Adam J Nelson, et al.
Pageof 3